clinical_trials
Why pharma firms are betting billions on psychedelic drugs despite setbacks
Confidence95·multiple reportsImportance97NP-EVT-20261027-B32E973
Nature, Published online: 27 October 2026; doi:10.1038/d41586-026-03390-8 Regulatory pushback stalled the field. But researchers are optimistic about mind-altering drugs as potential treatments for depression and mood disorders.
Read the original at the primary source
Why pharma firms are betting billions on psychedelic drugs despite setbacks
Lynne Peeples · 10/27/2026, 12:00:00 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —